In 2023, the number of incident tuberculosis cases in the US stood at an estimated value, around 8.26 thousand. From 2024 to 2028, a consistent decline is forecasted, with cases decreasing from 7.87 thousand to 6.38 thousand. The year-on-year decline is steady, with annual percentage decreases observed: approximately 4.8% in 2025, 5.1% in 2026, 5.1% in 2027, and 5.5% in 2028. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is approximately -4.76%.
Future trends to watch for:
- Impact of enhanced public health interventions on reducing TB incidence.
- Emergence and management of drug-resistant TB strains.
- Policy changes promoting early detection and efficient treatment.
